Caribou Biosciences (CRBU) Change in Acquisitions & Divestments (2022 - 2026)

Caribou Biosciences (CRBU) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $46.1 million in Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $46.1 million, down 30.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $233.0 million (down 36.4% YoY), and the FY2025 annual result was $252.8 million, down 36.39% from the prior year.
• Change in Acquisitions & Divestments declined to $46.1 million in Q1 2026 per CRBU's latest filing, from $61.8 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $120.7 million in Q3 2024 and troughed at $39.3 million in Q1 2022.
• A 5-year average of $75.7 million and a median of $68.4 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments jumped 151.06% in 2023, then sank 47.43% in 2025.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $89.7 million in 2022, then tumbled by 38.72% to $55.0 million in 2023, then surged by 30.81% to $71.9 million in 2024, then slipped by 14.11% to $61.8 million in 2025, then dropped by 25.32% to $46.1 million in 2026.
• Business Quant data shows CRBU's Change in Acquisitions & Divestments at $46.1 million in Q1 2026, $61.8 million in Q4 2025, and $68.4 million in Q3 2025.